Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

During the Trading Day
10.40 +0.21 / +2.06%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.40 +0.011 / +0.11%
 
Volume: 8.5K

Today’s Trading

Previous close10.19
Today’s open10.15
Day’s range10.08 - 10.80
Volume1,844,425
Average volume (3 months)1,768,384
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+22.85%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book12.85

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc-0.21-1.31%
FGENFibroGen Inc-0.40-2.15%
BRLIBio-Reference Labora...+0.12+0.36%
DBVTDBV Technologies SA-0.28-1.18%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
James F. Oliviero
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers